Harpoon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Harpoon Therapeutics

14/05/2022 24:28

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in March. The
mean expectation of ten analysts for the quarter was for a loss
of 55 cents per share.
    * Revenue fell 34.4% to $5.91 million from a year ago; 
analysts
expected $8.08 million. 
    * Harpoon Therapeutics Inc's reported EPS for the quarter
was a
loss of 62 cents​.
    * The mean earnings estimate of analysts had fallen by
about 35.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Harpoon Therapeutics Inc shares had fallen by 62.6% this
quarter and lost 75.4% so far this year.
    * The company reported a quarterly loss of $20.32 million.
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 11:28 p.m.  ​All
figures in US dollars unless otherwise stated